100% correct. Pomme is the star of the show, but Laverton is turning out to be a good little bonus on the side. Personally, I was a bit surprised by today's outcome, but there could be many factors for that, including some heavy duty 'tree-shaking' and other 'games'. Once we get a Pomme update (any day now), that should be a great catalyst for a recovery. Not to mention the other inbound news, including the other assays from Laverton.
MTM Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
